93 related articles for article (PubMed ID: 23643942)
1. Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation.
Li T; Liu Z; Jiang K; Ruan Q
Cancer Lett; 2013 Sep; 337(2):276-84. PubMed ID: 23643942
[TBL] [Abstract][Full Text] [Related]
2. Induction of chemoresistance by all-trans retinoic acid via a noncanonical signaling in multiple myeloma cells.
Liu Z; Li T; Jiang K; Huang Q; Chen Y; Qian F
PLoS One; 2014; 9(1):e85571. PubMed ID: 24416428
[TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
4. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activity of TAp63 promoter is regulated by c-jun.
Yao JY; Pao CC; Chen JK
J Cell Physiol; 2010 Nov; 225(3):898-904. PubMed ID: 20607803
[TBL] [Abstract][Full Text] [Related]
7. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
[TBL] [Abstract][Full Text] [Related]
8. Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins.
Arthur JS; Fong AL; Dwyer JM; Davare M; Reese E; Obrietan K; Impey S
J Neurosci; 2004 May; 24(18):4324-32. PubMed ID: 15128846
[TBL] [Abstract][Full Text] [Related]
9. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3.
Vicent GP; Ballaré C; Nacht AS; Clausell J; Subtil-Rodríguez A; Quiles I; Jordan A; Beato M
Mol Cell; 2006 Nov; 24(3):367-81. PubMed ID: 17081988
[TBL] [Abstract][Full Text] [Related]
10. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells.
Kim KL; Shin IS; Kim JM; Choi JH; Byun J; Jeon ES; Suh W; Kim DK
Cardiovasc Res; 2006 Dec; 72(3):394-402. PubMed ID: 17054925
[TBL] [Abstract][Full Text] [Related]
12. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
13. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic loss of CDH1 correlates with multidrug resistance in human hepatocellular carcinoma cells.
Jiang L; Chan JY; Fung KP
Biochem Biophys Res Commun; 2012 Jun; 422(4):739-44. PubMed ID: 22634315
[TBL] [Abstract][Full Text] [Related]
15. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin.
Fan L; Sun G; Ma T; Zhong F; Lei Y; Li X; Wei W
J Pineal Res; 2013 Sep; 55(2):184-94. PubMed ID: 23711089
[TBL] [Abstract][Full Text] [Related]
16. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
17. Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal transduction pathways.
Guberman AS; Scassa ME; Cánepa ET
Arch Biochem Biophys; 2005 Apr; 436(2):285-96. PubMed ID: 15797241
[TBL] [Abstract][Full Text] [Related]
18. Co-silencing of Birc5 (survivin) and Hspa5 (Grp78) induces apoptosis in hepatoma cells more efficiently than single gene interference.
Wang Q; Shu R; He H; Wang L; Ma Y; Zhu H; Wang Z; Wang S; Shen G; Lei P
Int J Oncol; 2012 Aug; 41(2):652-60. PubMed ID: 22581315
[TBL] [Abstract][Full Text] [Related]
19. IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway.
Kawaguchi M; Fujita J; Kokubu F; Huang SK; Homma T; Matsukura S; Adachi M; Hizawa N
Am J Physiol Lung Cell Mol Physiol; 2009 May; 296(5):L804-10. PubMed ID: 19251839
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
